Status:
COMPLETED
The Effect of Nebulized Albuterol on Donor Oxygenation
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
California Transplant Donor Network
University of California, San Francisco
Conditions:
Brain Death
Organ Donor
Eligibility:
All Genders
14+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to test the effectiveness of albuterol versus placebo with the following specific aims: a) Treatment of brain dead organ donors with albuterol will reduce pulmonary edema,...
Detailed Description
The donor lung utilization rate in the United States remains less than 15%, and the demand for donor lungs far exceeds the available supply. The most common reasons for failure to utilize donor lungs ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Brain death
- Consent for lung donation and donor research
- Release from coroner or medical examiner
- Exclusion Criteria
- Age less than 14 years
Exclusion
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
506 Patients enrolled
Trial Details
Trial ID
NCT00310401
Start Date
April 1 2007
End Date
June 1 2011
Last Update
March 16 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
California Transplant Donor Network
Oakland, California, United States, 94612